We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
112 hedge funds and large institutions have $833M invested in Atara Biotherapeutics in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 60 increasing their positions, 15 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 15
128% more call options, than puts
Call options by funds: $2.84M | Put options by funds: $1.25M
0.05% more ownership
Funds ownership: 4.34% → 4.39% (+0.05%)
3% less funds holding
Funds holding: 116 → 112 (-4)
15% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 26
18% less capital invested
Capital invested by funds: $1.01B → $833M (-$179M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
112
Holders Change
-4
Holders Change %
-3.45%
% of All Funds
2.46%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
22
Increased
60
Reduced
15
Closed
26
Calls
$2.84M
Puts
$1.25M
Net Calls
+$1.59M
Net Calls Change
-$1.03M
Top Buyers
| 1 |
MC
Maverick Capital
Dallas,
Texas
|
+$42.9M |
| 2 |
BG
Baupost Group
Boston,
Massachusetts
|
+$19.5M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$17.9M |
| 4 |
Morgan Stanley
New York
|
+$14.3M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$14.2M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$44.8M |
| 2 |
Neuberger Berman Group
New York
|
-$5.79M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.33M |
| 4 |
Millennium Management
New York
|
-$3.91M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.32M |
